SK
About
SkylineDx is an emerging commercial-stage company focused on the development and commercialization of innovative gene signature-based diagnostic tests, which assist healthcare professionals in making personalized treatment decisions for individual patients. These tests are designed to accurately determine the type or status of the disease or to predict a patient’s response to a specific treatment.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 120 investors are based in Rotterdam, Zuid-Holland, The Netherlands.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Rotterdam, The Netherlands
Contact Information
Find more investors like SkylineDx
Search Investors